Nicola Sgherza
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari(IT)University of Bari Aldo Moro(IT)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Protein Degradation and Inhibitors
Most-Cited Works
- → Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis(2019)145 cited
- → Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission(2018)105 cited
- → Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice(2019)76 cited
- → Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real‐life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart(2019)66 cited
- → Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients(2018)54 cited
- → Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors(2012)51 cited